Kura Oncology Inc buy melinda
Start price
06.06.17
/
50%
€7.44
Target price
05.07.17
€8.57
Performance (%)
15.51%
End price
05.07.17
€8.60
Summary
This prediction ended on 05.07.17 with a price of €8.60. The BUY prediction by melinda finished with a performance of 15.51%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kura Oncology Inc | 4.167% | 4.167% | 85.185% | 11.732% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% | 56.109% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% | 92.063% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% | 79.139% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% | 70.019% |
Comments by melinda for this prediction
In the thread Kura Oncology Inc diskutieren
Healthcare | Biotechnologie | USA
Anzeige der Phase 2 mit den Daten auf der Konferenz der European Hematology Association (EHA) ab Juni 22-25 2017. Das genaue Datum TBC.
Stopped prediction by melinda for Kura Oncology Inc
Kura Oncology Inc
Start price
Target price
Perf. (%)
€10.64
06.11.18
06.11.18
€14.34
10.12.18
10.12.18
16.15%
10.12.18
10.12.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€15.33
23.09.18
23.09.18
€16.51
06.11.18
06.11.18
-27.37%
06.11.18
06.11.18
Kura Oncology Inc
Start price
Target price
Perf. (%)
€8.45
10.08.17
10.08.17
€10.50
15.08.17
15.08.17
-25.44%
15.08.17
15.08.17